Plain-English translation of NCT06908356 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called PRAX-628 to see if it can help adults whose seizures aren't fully controlled even while taking their current anti-seizure medications. Researchers want to learn whether adding this treatment is safe and effective at reducing how often seizures happen. You would take the medication daily for 8 weeks while researchers monitor how well it works for you.
Many people with epilepsy continue to have seizures even when taking one, two, or three anti-seizure medications. This trial exists to find out whether this new medication might help people who haven't found complete seizure control with their current treatment plan.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would take 30 mg of the medication by mouth once daily for 8 weeks. During this time, you would attend study visits where researchers check how you are doing, ask about any side effects, and track how many seizures you are having. You would continue taking your regular anti-seizure medications as before. The study is open-label, which means both you and your doctor know you are receiving this new medication.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
United States